According to FutureWise analysis, the market for African Horse Sickness Treatment is estimated to be US$ 0.84 billion in 2023 and is expected to reach US$ 2.98 billion by 2031 at a CAGR of 17.20% over the forecast period of 2025-2033.
African horse sickness (AHS) is a severe and frequently lethal illness brought on by the African horse sickness virus. This disease is characterized by nine different serotypes; each associated with the virus. AHS is not transmitted directly between animals; instead, it spreads through various insect vectors. The primary hosts affected by AHS include horses, mules, donkeys, and zebras. While other animals such as elephants, camels, and dogs can become infected, they typically exhibit few, if any, symptoms—often acquiring the virus through the consumption of infected horse meat. Key insect vectors responsible for the spread of AHS include Culicoides midges, mosquitoes (notably Culex, Anopheles, and Aedes species, including A. aegypti), as well as certain tick species such as Hyalomma and Rhipicephalus.
FutureWise Market Research has published a report that provides an insightful analysis of African Horse Sickness Treatment trends that are affecting the overall market growth.
Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=13510%20&type=requestsample
African Horse Sickness Treatment Segmentation:
By Clinical Forms of The Disease
By Diagnosis of the Disease And Prevention Strategies
By Region
Competitive Landscape in African Horse Sickness Treatment:
Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=13510&license=multi
**Objectives of this Study: **
Flexible Delivery Model: